We’re a different kind of global biopharmaceutical company.
Discover more
Nine consecutive quarters of growth in Q1 2025 with key innovative medicines growing ~40%; 2025 profit outlook improved
Teva has been committed to supporting people with neurological conditions for over 30 years. Hear about the latest innovative advancements from our global medical experts.
Our latest Healthy Future Report shows the steps Teva is taking for the health of people, the planet and our business.